Deciphering temporal antifungal dynamics of a rare actinomycete via integrated omics.

All biosynthetic gene clusters in Saccharomonospora xinjiangensis XJ-54 show growth-phase-dependent transcriptional activity, producing antifungal metabolites through coordinated biosynthetic programs.

• Why it matters: Natural product discovery has mainly focused on Streptomyces, leaving rare actinomycetes underexplored despite their potential to yield novel antifungal compounds critical for sustainable agriculture.
• What they did: The study integrated genomic, transcriptomic, and metabolomic analyses of S. xinjiangensis XJ-54, revealing that all BGCs are transcriptionally active with distinct growth-phase-dependent expression patterns, and identified growth-phase-specific metabolites linked to antifungal activity.
• The result: Findings suggest that temporally coordinated biosynthetic programs enable antifungal metabolite production, providing a framework for optimizing cultivation and prioritizing BGCs for functional characterization to accelerate natural product discovery.